IVIG-mediated protection against necrotizing pneumonia caused by MRSA

Science Translational Medicine

Volumn 8, Issue 357, 2016, Pages

  Diep, Binh An ^a   Le, Vien T M ^a   Badiou, Cedric ^b,c   Le, Hoan N ^a   Pinheiro, Marcos Gabriel ^a,d   Duong, Au H ^a   Wang, Xing ^a   Dip, Etyene Castro ^a   Aguiar Alves, Fábio ^a,d   Basuino, Li ^a   Marbach, Helene ^a   Mai, Thuy T ^a   Sarda, Marie N ^e   Kajikawa, Osamu ^f   Matute Bello, Gustavo ^f   Tkaczyk, Christine ^g   Rasigade, Jean Philippe ^b,c   Sellman, Bret R ^g   Chambers, Henry F ^a   Lina, Gerard ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; IMMUNOGLOBULIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS TOXIN; VANCOMYCIN; BACTERIAL TOXIN; EXOTOXIN; HEMOLYSIN; LEUKOCIDIN; NEUTRALIZING ANTIBODY; PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCAL ALPHA-TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; ACUTE LUNG INJURY; ANIMAL; ANTIBIOTIC PROPHYLAXIS; DISEASE MODEL; IMMUNOLOGY; LEPORIDAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NECROTIZING PNEUMONIA; PATHOLOGY; PHYSIOLOGY;

ACUTE LUNG INJURY; ANIMALS; ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, NEUTRALIZING; BACTERIAL TOXINS; DISEASE MODELS, ANIMAL; EXOTOXINS; HEMOLYSIN PROTEINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCIDINS; LINEZOLID; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, NECROTIZING; RABBITS; VANCOMYCIN;

EID: 84988874932     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aag1153     Document Type: Article

References (36)

1. A. I. Hidron, C. E. Low, E. G. Honig, H. M. Blumberg, Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising communityonset pneumonia. Lancet Infect. Dis. 9, 384-392 (2009).
2. V. Gauduchon, G. Cozon, F. Vandenesch, A.-L. Genestier, N. Eyssade, S. Peyrol, J. Etienne, G. Lina, Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J. Infect. Dis. 189, 346-353 (2004).
3. D. Nathwani, M. Morgan, R. G. Masterton, M. Dryden, B. D. Cookson, G. French, D. Lewis; British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections, Guidelines for UK practice for the diagnosis and management of methicillinresistant Staphylococcus aureus (MRSA) infections presenting in the community. J. Antimicrob. Chemother. 61, 976-994 (2008).
4. M. Barton, M. Hawkes, D. Moore, J. Conly, L. Nicolle, U. Allen, N. Boyd, J. Embree, L. Van Horne, N. Le Saux, S. Richardson, A. Moore, D. Tran, V. Waters, M. Vearncombe, K. Katz, J. S. Weese, J. Embil, M. Ofner-Agostini, E. L. Ford-Jones; Writing Group of the Expert Panel of Canadian Infectious Disease, Infection Prevention and Control, Public Health Specialists, Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners. Can. J. Infect. Dis. Med. Microbiol. 17, 4C-24C (2006).
5. C. Liu, A. Bayer, S. E. Cosgrove, R. S.Daum, S. K. Fridkin, R. J.Gorwitz, S. L. Kaplan, A.W. Karchmer, D. P. Levine, B. E. Murray, M. J. Rybak, D. A. Talan, H. F. Chambers, Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary. Clin. Infect. Dis. 52, 285-292 (2011).
6. N. Rouzic, F. Janvier, N. Libert, E. Javouhey, G. Lina, J.-Y. Nizou, P. Pasquier, D. Stamm, L. Brinquin, C. Pelletier, F. Vandenesch, D. Floret, J. Etienne, Y. Gillet, Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes. J. Clin. Microbiol. 48, 1952-1955 (2010).
7. N. Libert, E. Batjom, A. Cirodde, S. de Rudnicki, L. Grasser, M. Borne, L. Brinquin, Antitoxin treatments for necrotizing pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Med. Mal. Infect. 39, 14-20 (2009).
8. C. Salliot, V. Zeller, X. Puechal, V. Manceron, S. Sire, N. Varache, J. Etienne, N. Desplaces, J.-M. Ziza, Panton-Valentine leukocidin-producing Staphylococcus aureus infections: Report of 4 French cases. Scand. J. Infect. Dis. 38, 192-195 (2006).
9. F. G. Hampson, S. W. Hancock, R. A. Primhak, Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired meticillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy. Arch. Dis. Child. 91, 201 (2006).
10. M. M. Alejandria, M. A. Lansang, L. F. Dans, J. B. Mantaring III, Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst. Rev. 9, CD001090 (2013).
11. B. A. Diep, L. Chan, P. Tattevin, O. Kajikawa, T. R. Martin, L. Basuino, T. T. Mai, H. Marbach, K. R. Braughton, A. R. Whitney, D. J. Gardner, X. Fan, C. W. Tseng, G. Y. Liu, C. Badiou, J. Etienne, G. Lina, M. A. Matthay, F. R. DeLeo, H. F. Chambers, Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc. Natl. Acad. Sci. U.S.A. 107, 5587-5592 (2010).
12. B. Löffler, M. Hussain, M. Grundmeier, M. Brück, D. Holzinger, G. Varga, J. Roth, B. C. Kahl, R. A. Proctor, G. Peters, Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLOS Pathog. 6, e1000715 (2010).
13. A. N. Spaan, T. Henry, W. J. van Rooijen, M. Perret, C. Badiou, P. C. Aerts, J. Kemmink, C. J. C. de Haas, K. P. M. van Kessel, F. Vandenesch, G. Lina, J. A. G. van Strijp, The staphylococcal toxin Panton-Valentine leukocidin targets human C5a receptors. Cell Host Microbe 13, 584-594 (2013).
14. L. K. McDougal, C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, F. C. Tenover, Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: Establishing a national database. J. Clin. Microbiol. 41, 5113-5120 (2003).
15. J. Darenberg, B. Soderquist, B. H. Normark, A. Norrby-Teglund, Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: Implications for therapy of toxic shock syndrome. Clin. Infect. Dis. 38, 836-842 (2004).
16. B. A. Diep, A. Afasizheva, H. N. Le, O. Kajikawa, G. Matute-Bello, C. Tkaczyk, B. Sellman, C. Badiou, G. Lina, H. F. Chambers, Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillinresistant Staphylococcus aureus necrotizing pneumonia. J. Infect. Dis. 208, 75-82 (2013).
17. T. Darville, L. B. Milligan, K. K. Laffoon, Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production. Infect. Immun. 65, 366-372 (1997).
18. G. J. Wilson, K. S. Seo, R. A. Cartwright, T. Connelley, O. N. Chuang-Smith, J. A. Merriman, C. M. Guinane, J. Y. Park, G. A. Bohach, P. M. Schlievert, W. I. Morrison, J. R. Fitzgerald, A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLOS Pathog. 7, e1002271 (2011).
19. W. Salgado-Pabón, L. Breshears, A. R. Spaulding, J. A. Merriman, C. S. Stach, A. R. Horswill, M. L. Peterson, P. M. Schlievert, Superantigens are critical for Staphylococcus aureus infective endocarditis, sepsis, and acute kidney injury. mBio 4, e00494-13 (2013).
20. G. Y. C. Cheung, R. Wang, B. A. Khan, D. E. Sturdevant, M. Otto, Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect. Immun. 79, 1927-1935 (2011).
21. M. Z. David, K. M. Rudolph, T. W. Hennessy, S. Boyle-Vavra, R. S. Daum, Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska. Emerg. Infect. Dis. 14, 1693-1699 (2008).
22. S. Takei, Y. K. Arora, S. M. Walker, Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J. Clin. Invest. 91, 602-607 (1993).
23. S. Bhakdi, U. Mannhardt, M. Muhly, F. Hugo, H. Ronneberger, K.-D. Hungerer, Human hyperimmune globulin protects against the cytotoxic action of staphylococcal alpha-toxin in vitro and in vivo. Infect. Immun. 57, 3214-3220 (1989).
24. J. H. Vernachio, A. S. Bayer, B. Ames, D. Bryant, B. D. Prater, P. J. Syribeys, E. L. Gorovits, J. M. Patti, Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrob. Agents Chemother. 50, 511-518 (2006).
25. U. Seybold, E. V. Kourbatova, J. G. Johnson, S. J. Halvosa, Y. F. Wang, M. D. King, S. M. Ray, H. M. Blumberg, Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42, 647-656 (2006).
26. H. R. Rose, R. S. Holzman, D. R. Altman, D. S. Smyth, G. A. Wasserman, J. M. Kafer, M. Wible, R. E. Mendes, V. J. Torres, B. Shopsin, Cytotoxic virulence predicts mortality in nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 211, 1862-1874 (2015).
27. L. Stulik, S. Malafa, J. Hudcova, H. Rouha, B. Z. Henics, D. E. Craven, A. M. Sonnevend, E. Nagy, a-Hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilatorassociated pneumonia. Am. J. Respir. Crit. Care Med. 190, 1139-1148 (2014).
28. E. W. Gelfand, Intravenous immune globulin in autoimmune and inflammatory diseases. N. Engl. J. Med. 367, 2015-2025 (2012).
29. L. Maródi, A. Kalmár, L. Karmazsin, Stimulation of the respiratory burst and promotion of bacterial killing in human granulocytes by intravenous immunoglobulin preparations. Clin. Exp. Immunol. 79, 164-169 (1990).
30. E. Glowalla, B. Tosetti, M. Krönke, O. Krut, Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus. Infect. Immun. 77, 2719-2729 (2009).
31. C. S. Munro, P. J. Stanley, P. J. Cole, Assessment of biological activity of immunoglobulin preparations by using opsonized micro-organisms to stimulate neutrophil chemiluminescence. Clin. Exp. Immunol. 61, 183-188 (1985).
32. G. Rajam, G. M. Hammons, G. M. Carlone, J. S. Sampson, E. W. Ades, A novel innate immuneenhancement strategy combined with IVIG rescues mice from fatal Staphylococcus aureus septicemia. Int. J. Microbiol. 2011, 725483 (2011).
33. M.-F. Shaio, K. D. Yang, J. F. Bohnsack, H. R. Hill, Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum. Pediatr. Res. 25, 634-640 (1989).
34. T. Bae, O. Schneewind, Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55, 58-63 (2006).
35. F. Vandenesch, T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M. E. Reverdy, J. Etienne, Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg. Infect. Dis. 9, 978-984 (2003).
36. B. A. Diep, H. A. Carleton, R. F. Chang, G. F. Sensabaugh, F. Perdreau-Remington, Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillinresistant Staphylococcus aureus. J. Infect. Dis. 193, 1495-1503 (2006).